Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Proteus International rose 8p to 48.5p as interest grew in its BSE detection system. An Irish company has successfully completed a field survey of the development which is aimed at diagnosing the disease in hours and could be used in slaughterhouses. The Dublin Government is keen. There are suggestion that if final tests are successful it will make them mandatory and press for adoption across Europe. Like most biotech groups Proteus, with close links to ML Laboratories, has had an erratic ride. It shares nearly hit 400p in 1994.
Tradepoint, the stock market in miniature which was expected to boom with the advent of order driven trading, fell 7.5p to 65p. The shares touched 148.5p as the new order arrived and Tradepoint benefited from a cash injection.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments